Actavis, Others Infriged Endo's Opana Patents, Judge Says

By Vin Gurrieri (August 14, 2015, 8:29 PM EDT) -- A New York federal judge on Friday ruled that Actavis Inc. and other drug manufacturers infringed most of the claims of Endo Pharmaceuticals Inc.'s patents related to the painkiller Opana ER, ordering Actavis to pull its generic version from the market and blocking any other proposed generics from launching....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!